These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2414494)

  • 21. Transurethral resection of bladder tumour: is day-case surgery appropriate?
    Kockelbergh R
    BJU Int; 2005 Oct; 96(6):746-7. PubMed ID: 16153190
    [No Abstract]   [Full Text] [Related]  

  • 22. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
    Herr HW; Donat SM; Dalbagni G
    J Urol; 2007 Jan; 177(1):75-9; discussion 79. PubMed ID: 17162005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of the urethra in patients undergoing radical cystectomy for bladder carcinoma.
    Baron JC; Boccon-Gibod L; Steg A
    Prog Clin Biol Res; 1989; 303():591-6. PubMed ID: 2780663
    [No Abstract]   [Full Text] [Related]  

  • 24. The value of a second transurethral resection in evaluating patients with bladder tumors.
    Herr HW
    J Urol; 1999 Jul; 162(1):74-6. PubMed ID: 10379743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transurethral resection (TUR) in the therapy of bladder tumors (a review of 483 cases).
    Balogh F; Kisbenedek L
    Int Urol Nephrol; 1982; 14(2):143-9. PubMed ID: 6181002
    [No Abstract]   [Full Text] [Related]  

  • 26. Transurethral resection for muscle-invasive bladder cancer.
    Kondás J; Váczi L; Szecsó L; Kondér G
    Int Urol Nephrol; 1993; 25(6):557-63. PubMed ID: 8175277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transurethral resection of superficial bladder cancer: technically safe, oncologically anything but perfect.
    Grimm MO; Ackermann R
    J Urol; 2005 Dec; 174(6):2086-7. PubMed ID: 16280732
    [No Abstract]   [Full Text] [Related]  

  • 28. [Possibilities and limitations of transurethral surgery in carcinoma of the bladder].
    Mauermayer W
    Urologe A; 1973 Mar; 12(2):55-8. PubMed ID: 4121440
    [No Abstract]   [Full Text] [Related]  

  • 29. [Role of fluorescent control in raising radicality of surgical treatment for superficial bladder cancer].
    Matveev BP; Kudashev BV; Bukharkin BV; Romanov VA; Rubanov IuV
    Urologiia; 2000; (3):22-4. PubMed ID: 11186703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nd. Yag treatment of bladder tumors].
    Kardos R; Magasi P; Karsza A
    Orv Hetil; 1994 Feb; 135(8):395-7. PubMed ID: 8139841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of simultaneous transurethral resection of prostate and solitary bladder tumors smaller than 3 cm on oncologic results.
    Ugurlu O; Gonulalan U; Adsan O; Kosan M; Oztekin V; Cetinkaya M
    Urology; 2007 Jul; 70(1):55-9. PubMed ID: 17656208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The value of antibiotic prophylaxis in transurethral resection of bladder tumors. Apropos of 61 cases].
    Delavierre D; Huiban B; Fournier G; Le Gall G; Tande D; Mangin P
    Prog Urol; 1993; 3(4):577-82. PubMed ID: 8401618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
    Herr HW
    J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Novocaine infiltration of the obturator nerve during transurethral resection of bladder tumors].
    Viville C; Durand de Grossouvre P
    Acta Urol Belg; 1980 Jan; 48(1):49-55. PubMed ID: 7192048
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fluorescent cystoscopy and transurethral electroresection in diagnosis and treatment of patients with invasive cancer of the urinary bladder].
    Komiakov BK; Gorelov SI; Novikov AI; Gorelov AI; Novikov PB; Strokova LA; Al-Atar T
    Urologiia; 2004; (6):37-40. PubMed ID: 15719729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single instillation of mitomycin C reduces 1st year recurrence following transurethral resection of non-muscle invasive bladder cancer.
    Ather MH; Aziz S; Sulaiman MN
    J Ayub Med Coll Abbottabad; 2007; 19(4):18-20. PubMed ID: 18693589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Manual for pre- and postoperative patient care. Bladder cancer].
    Tsuchimoto K; Watanabe N; Anzai C
    Kango Gijutsu; 1989 Jan; 35(2):202-5. PubMed ID: 2467028
    [No Abstract]   [Full Text] [Related]  

  • 38. Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma.
    Li LY; Yang M; Zhang HB; Su XK; Xu WF; Chen Y; Shen ZJ; Gao X
    BJU Int; 2008 Aug; 102(5):566-71. PubMed ID: 18410436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An analysis of complications following transurethral resection of bladder tumors].
    Kasztelan Z
    Z Urol Nephrol; 1983 Jun; 76(6):383-7. PubMed ID: 6637165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug prevention of recurrence in bladder tumors. Intravesical adriblastin instillation following transurethral resection of non-infiltrating bladder tumors].
    Maier U; Kuber W
    Fortschr Med; 1983 Mar; 101(12):535-40. PubMed ID: 6852720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.